Skip to main content

Aptevo Therapeutics Inc (APVO) Stock

Aptevo Therapeutics Inc Stock Details, Movements and Public Alerts

Stock Details

Aptevo Therapeutics Inc (APVO), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $4.68. Over the past 52 weeks, it has ranged between $3.95 and $1,299.60. This places the current price at 0.4% of its 52-week high and 18.5% above its 52-week low. Recent trading volume was recorded at 43,925. The 14-day Relative Strength Index (RSI) stands at 35.11, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $10.90 by 57.06%. Similarly, it is below its 200-day moving average of $39.48 by 88.15%. The MACD histogram is 0.31, indicating bullish momentum (MACD Line: -1.15, Signal Line: -1.46).

52-Week Range

$1,299.60 - $3.95

-99.64% from high · +18.48% from low

Avg Daily Volume

48,946

20-day average

100-day avg: 1,554,237

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

0.00

Below market average

Forward P/E

3.94

Earnings expected to decline

PEG Ratio

0.00

Potentially undervalued

Price to Book

0.25

EV/EBITDA

0.39

EPS (TTM)

$7,758.20

Price to Sales

1.61

Beta

1.43

Similar volatility to market

Q:How is APVO valued relative to its earnings and growth?
Aptevo Therapeutics Inc trades at a P/E ratio of 0.00, which is below the market average of approximately 20. This lower valuation could indicate the market has modest growth expectations, or it might represent an undervalued opportunity if the fundamentals are strong. Looking ahead, the forward P/E of 3.94 is higher than the current P/E, indicating analysts expect earnings to decline over the next year.0
Q:What is APVO's risk profile compared to the market?
With a beta of 1.43, Aptevo Therapeutics Inc is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 0.25 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-26,468,000

Return on Equity

-242.70%

Return on Assets

-79.20%

Revenue Growth (YoY)

-100.00%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is APVO's business model?
Profitability metrics are not available for this stock.
Q:What are APVO's recent growth trends?
Aptevo Therapeutics Inc's revenue declined by 100.00% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions.0 These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Market Cap

$6.9M

Revenue (TTM)

$0

Revenue/Share (TTM)

$0.00

Shares Outstanding

1.56M

Book Value/Share

$22.67

Asset Type

Common Stock

Q:What is APVO's market capitalization and position?
Aptevo Therapeutics Inc has a market capitalization of $6.9M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 1.56M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
Q:How does APVO's price compare to its book value?
Aptevo Therapeutics Inc's book value per share is $22.67, while the current stock price is $4.68, resulting in a price-to-book (P/B) ratio of 0.21. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$21.00

348.72% upside potential

Analyst Recommendations

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for APVO?
1 analysts cover APVO with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $21.00 implies 348.7% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on APVO?
Current analyst recommendations:01 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Mar 15, 2026, 02:43 AM

Technical Indicators

RSI (14-day)

35.11

Neutral

50-Day Moving Average

$10.90

-57.06% below MA-50

200-Day Moving Average

$39.48

-88.15% below MA-200

MACD Line

-1.15

MACD Signal

-1.46

MACD Histogram

0.31

Bullish

Q:What does APVO's RSI value tell investors?
The RSI (Relative Strength Index) for APVO is currently 35.11, indicating the stock is showing bearish momentum (30-40 range). Selling pressure is evident but not extreme. This often occurs during pullbacks in uptrends or early stages of downtrends. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
Q:How should traders interpret APVO's MACD and moving average crossovers?
MACD analysis shows the MACD line at -1.15 above the signal line at -1.46, with histogram at 0.31. This bullish crossover suggests upward momentum is building. The 50-day MA ($10.90) is below the 200-day MA ($39.48), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Feb 21, 2026, 12:31 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for APVO and get notified when the price changes.

Stay Ahead of the Market with Aptevo Therapeutics Inc Alerts

Set up price alerts for Aptevo Therapeutics Inc and get notified instantly when the price hits your target. Never miss an important price movement again.